Autopsy report · NCT00893789

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

“Study has been stopped by sponsor decision.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 9 months before it stopped.
• 117 participants enrolled.
• Results were posted on the registry 2 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Cephalon, Inc.

Sponsor type

Industry

Conditions

Traumatic Brain Injury

Interventions

Armodafinil; Armodafinil; Armodafinil; Placebo

Participants

117

Sites

73

Countries

Germany, Italy, Spain, United States

Trials that died the same way

• Safety and Efficacy of Medical Cannabis Oil in the Treatment of Patients with Chronic Pain
  “Sponsor decision to stop the study” (94% match in meaning)
• Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
  “The sponsor has decided to stop the study” (94% match in meaning)
• the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period
  “the sponsor decided to stop the study” (93% match in meaning)
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
  “Study was stopped by the Sponsor” (92% match in meaning)
• Parkinson's Disease G2019S LRRK2 Genetic Testing Program
  “Sponsor stopped the study” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.